Neuraxis Q2 EPS $(1.21) Down From $(0.87) YoY, Sales $646.00K Down From $682.60K YoY
Portfolio Pulse from Benzinga Newsdesk
Neuraxis (AMEX:NRXS) reported Q2 losses of $(1.21) per share, a 39.08% decrease YoY. Sales also decreased by 5.36% to $646.00K compared to the same period last year.
September 21, 2023 | 12:13 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Neuraxis reported a YoY decrease in Q2 earnings and sales, which could negatively impact its stock price.
Neuraxis reported a decrease in both earnings per share and sales compared to the same period last year. This indicates a potential decline in the company's financial performance, which could negatively impact investor sentiment and lead to a decrease in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100